Indivior PLC (LON:INDV – Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 888.47 ($11.86) and traded as low as GBX 676.23 ($9.03). Indivior shares last traded at GBX 680 ($9.08), with a volume of 363,132 shares.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 1,500 ($20.02) price objective on shares of Indivior in a report on Thursday, September 5th.
Check Out Our Latest Analysis on Indivior
Indivior Price Performance
Insider Buying and Selling
In other news, insider Jo Le Couilliard acquired 1,490 shares of Indivior stock in a transaction that occurred on Friday, July 26th. The stock was purchased at an average cost of GBX 1,006 ($13.43) per share, with a total value of £14,989.40 ($20,007.21). 3.39% of the stock is currently owned by insiders.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Further Reading
- Five stocks we like better than Indivior
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- The Average 401k Balance by Age Explained
- Short Selling: How to Short a Stock
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.